IspecimenISPC

13F holders, Q2 2025 (June 30)
9holders +1
2new positions
1sold out
1famous investor
$0.98avg. 13F price*

At the end of Q2 2025, 9 institutions reported holding Ispecimen Inc. (ISPC) in their 13F filings, up 1 from Q1 2025. 2 opened new positions and 1 sold out. The largest holders were Citadel Advisors ($19K), Geode Capital Management, LLC ($15K) and UBS Group AG ($14K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Ispecimen Inc.
CUSIP
45032V207
Latest filing quarter
Q2 2026

History

Number of 13F holders

051015 Q3 2024: 6Q3 2024Q4 2024: 7Q4 2024Q1 2025: 8Q1 2025Q2 2025: 9Q2 2025Q3 2025: 12Q3 2025Q4 2025: 11Q4 2025Q1 2026: 11Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions2$29K
Exits1$23K

All 13F filers, Q1 2025 → Q2 2025: 36,848 shares bought and 29,481 shares sold, net +7,367 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 9 holders

Citadel Advisors 0.00% New 19,464 $19K
Geode Capital Management, LLC 0.00% Add +38.0% 14,809 $15K
UBS Group AG 0.00% Reduce -35.4% 14,030 $14K
XTX Topco Ltd 0.00% New 10,084 $10K
Tower Research Capital LLC (TRC) 0.00% Add +107.5% 6,186 $6K
BlackRock, Inc. 0.00% No change 2,827 $3K
Bank of America Corp. 0.00% Add +214.3% 22 $22
SBI Securities Co., Ltd. 0.00% Add +250.0% 7 $7
Sachetta, LLC 0.00% No change 2 $2

"% of holder's portfolio" is ISPC's weight in each manager's 13F, not the share of Ispecimen Inc. the manager owns.